School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, China.
School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, China.
J Mol Cell Cardiol. 2019 Feb;127:57-66. doi: 10.1016/j.yjmcc.2018.11.005. Epub 2018 Nov 14.
Endothelial progenitor cells (EPCs) play a crucial role in postnatal angiogenesis and neovascularization. Inward rectifier potassium channel 2.1 (Kir2.1) have been identified in EPCs. However, the effect of Kir2.1 on EPC function is not known. Here, we try to establish the role of Kir2.1 channels in EPC function and to provide first insights into the mechanisms.
We first observed that the expression of Kir2.1 gradually decreased with the differentiation of EPCs into ECs in gene and protein levels. Treatment with the Kir2.1-selective inhibitor ML133 or knockdown of Kir2.1 by shRNA triggered EPC depolarization and promoted EPC biological functions, such as migration, adhesion, angiogenesis and differentiation into ECs in vitro. Transplantation of ML133-treated or Kir2.1 knockdown EPCs facilitated re-endothelialization in the rat injured arterial segment and inhibited neointima formation in vivo. In parallel, ML133 significantly enhanced autophagy and autophagic flux. After suppression of autophagy by 3-methyladenine (3-MA), the effects of ML133 on in vitro function and in vivo endothelialization capacity of EPCs were significantly inhibited. Mechanistically, ML133-induced autophagy was mediated at least partly by increased the activity of reactive oxygen species (ROS) that likely through intracellular calcium.
Our study indicates that blocking or knockdown Kir2.1 results in a moderate depolarization of EPCs, which directly participated in enhancing EPC functions both in vitro and in vivo. In the mean time, autophagy signaling pathway is, at least in part, involved in this process. It may provide a potential target for the treatment or prevention of vascular injury and disease.
内皮祖细胞(EPCs)在出生后血管生成和新血管形成中发挥着关键作用。内向整流钾通道 2.1(Kir2.1)已在 EPCs 中被鉴定出来。然而,Kir2.1 对 EPC 功能的影响尚不清楚。在这里,我们试图确定 Kir2.1 通道在 EPC 功能中的作用,并为该机制提供初步见解。
我们首先观察到,随着 EPC 向 ECs 分化,Kir2.1 的表达在基因和蛋白水平上逐渐降低。用 Kir2.1 选择性抑制剂 ML133 处理或用 shRNA 敲低 Kir2.1 会引发 EPC 去极化,并促进 EPC 的生物学功能,如体外迁移、黏附、血管生成和分化为 ECs。用 ML133 处理或 Kir2.1 敲低的 EPC 移植促进了大鼠损伤动脉段的再内皮化,并抑制了体内新生内膜形成。与此平行,ML133 显著增强了自噬和自噬流。在用 3-甲基腺嘌呤(3-MA)抑制自噬后,ML133 对 EPC 体外功能和体内内皮化能力的作用明显受到抑制。从机制上讲,ML133 诱导的自噬至少部分是通过增加活性氧(ROS)的活性介导的,而 ROS 可能通过细胞内钙起作用。
我们的研究表明,阻断或敲低 Kir2.1 会导致 EPCs 发生适度去极化,这直接参与了体外和体内增强 EPC 功能。同时,自噬信号通路至少部分参与了这一过程。它可能为血管损伤和疾病的治疗或预防提供一个潜在的靶点。